Option Care Health (NASDAQ:OPCH) Releases Q4 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its fourth quarter earnings guidance on Monday. The company provided earnings per share guidance of $0.42-0.45 for the period, compared to the consensus earnings per share estimate of $0.35. The company issued revenue guidance of $1.34-1.35 billion, compared to the consensus revenue estimate of $1.27 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Option Care Health Stock Up 15.5 %

NASDAQ:OPCH opened at $27.72 on Tuesday. The company has a market capitalization of $4.72 billion, a price-to-earnings ratio of 23.29, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The stock has a 50-day simple moving average of $23.20 and a 200 day simple moving average of $27.69. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a one year low of $21.39 and a one year high of $34.63.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $26.00 to $33.00 in a research report on Monday. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday. Truist Financial reduced their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $29.71.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.